Evidence map›Paper›PMID 30697724›Full record

ArticleJournal of cellular physiology2019

Inhibition of Nrf2 promotes the antitumor effect of Pinelliae rhizome in papillary thyroid cancer.

Zhipeng Du, Qiang Wang, Guanjun Ma, Jianpeng Jiao, Daozhen Jiang, Xiangmin Zheng, Ming Qiu, Sheng Liu

Abstract read
In one paragraph

Article in Journal of cellular physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Mechanism research on inhibition of gastric cancerOpen medicine (Warsaw, Poland) · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. The Keap1/Nrf2 Signaling Pathway in the Thyroid-2020 Update.Antioxidants (Basel, Switzerland) · 2020
    Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zhipeng DuDepartment of General Surgery III, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Qiang WangDepartment of General Surgery III, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Guanjun MaDepartment of General Surgery III, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Jianpeng JiaoDepartment of Traditional Chinese Medicine, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Daozhen JiangDepartment of General Surgery III, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Xiangmin ZhengDepartment of General Surgery III, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Ming QiuDepartment of General Surgery III, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Sheng LiuDepartment of General Surgery III, Changzheng Hospital, Second Military Medical University, Shanghai, China.ORCID 0000-0001-5351-1742
Second Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously reported that Xiaotan Sanjie (XTSJ) decoction can prevent the progression of gastric cancer in vitro and in vivo. Pinelliae rhizome (PR), one component of XTSJ decoction, has an inhibitory effect on the growth and proliferation of tumor cells. The present study investigated the underlying mechanisms of action of PR. Using the human papillary thyroid cancer cell lines, TPC-1 and BCPAP, we found that XTSJ decoction and PR alone decreased cell viability to a similar extent in both cell lines, whereas treatment with XTJS decoction without PR [PR (-)] had a lesser effect. PR treatment inhibited the expression of nuclear factor erythroid 2-related factor 2 (Nrf2) in a dose-dependent manner. To investigate the role of Nrf2 in the PR-mediated effects of XTSJ, knockdown of Nrf2 in the tumor cell lines using Nrf2 siRNA (siNrf2) was performed and transfected cells were treated with PR. Silencing of Nrf2 amplified the effects on autophagy, cell viability, apoptosis, and colony formation. Similar results were obtained following treatment with the autophagy inhibitor 3-methyladenine (3-MA). Furthermore, treatment with PR, siNrf2, and/or 3-MA inhibited the MAPK pathway, and analysis of the MAPK pathway components confirmed the role of this pathway in the PR-mediated cellular effects. In mice implanted with siNrf2-transfected cells, the effects of PR were amplified. Taken together, these findings indicate that PR is critical for the inhibitory effects of XTSJ decoction on tumor cell viability and that downregulation of Nrf2 promotes the antitumor effects of PR on papillary thyroid cancer cells.

Indexed as

AnimalsAntineoplastic AgentsCell Line, TumorCell NucleusCell SurvivalDrugs, Chinese HerbalHumansMAP Kinase Signaling SystemMice, Inbred C57BLMice, KnockoutNF-E2-Related Factor 2PinelliaThyroid Cancer, PapillaryThyroid NeoplasmsAntineoplastic AgentsDrugs, Chinese HerbalNF-E2-Related Factor 2xiaotan sanjieautophagyMAPK pathwayNrf2papillary thyroid cancerPinelliae rhizomeXiaotan Sanjie decoction

Identifiers

PMID30697724
PMCPMC13483009
OpenAlexW2913940207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.